Biogen Inc. (NASDAQ:BIIB) is one of the best stem cell therapy stocks to buy. On April 22, Biogen Inc. (NASDAQ:BIIB) was upgraded to Buy from Neutral by UBS, with the firm adjusting the price target ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisation to Biogen for a ...

India’s Sun Pharmaceutical Industries agrees to buy the women’s health company for $14 a share in an all-cash deal.

As global markets navigate a complex landscape marked by geopolitical tensions and economic shifts, the Asian tech sector continues to capture attention with its potential for high growth, especially ...

Cambridge's Nobel Laureate Sir Greg Winter is championing a new global award designed to recognise outstanding science and ...

Here are five key things investors need to know to start the trading day.

Already the largest biopharma company in India, generics powerhouse Sun Pharma has doubled in size with its acquisition (PDF) ...

Jerome Powell's penultimate meeting as Federal Reserve chair and a slate of earnings reports from five out of the seven ...